title: Off-target effects related to the phosphorothioate modification of nucleic acids.
abstract: Phosphorothioate antisense oligonucleotides have been widely used in clinical studies for rational sequence-specific gene silencing. However, several sequence-unspecific off-target effects have been recently described for this compound class. In contrast to siRNA-mediated knockdown of the same gene, the bcl-2-targeted oblimersen (Genasense, G3139) downregulates a number of proteins involved in apoptotic resistance and several glycolytic enzymes in 607B human melanoma cells. Regardless of their target, phosphorothioate-modified antisense and siRNA compounds, but not oligonucleotides with a phosphodiester backbone, resulted in a similar impact on the proteome. Unspecifically downregulated proteins include cancer markers involved in apoptotic resistance and endoplasmatic reticulum (ER) stress such as the 78 kDa glucose regulated protein (GRP 78), protein disulfide isomerase A3 (PDIA3, GRP 58), calumenin, and galectin-1, as well as the glycolytic enzymes triose phosphate isomerase, glyceraldehyde phosphodehydrogenase, and phosphoglycerate mutase. The depletion of the glycolytic enzymes is reflected by a decrease in L-lactate production, indicating a partial reversal of the Warburg effect. Compared with other phosphorothioate oligonucleotides, oblimersen generally led to a more pronounced effect both in terms of the number of influenced proteins and the extent of downregulation, suggesting a synergistic effect of Bcl-2 downregulation.
authors.affiliation: Department of Medicinal Chemistry, University of Vienna, Austria. johannes.winkler@univie.ac.at
authors.forename: Johannes
authors.initials: J
authors.lastname: Winkler
authors.forename: Martina
authors.initials: M
authors.lastname: Stessl
authors.forename: Jennifer
authors.initials: J
authors.lastname: Amartey
authors.forename: Christian R
authors.initials: CR
authors.lastname: Noe
mesh_terms: D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000378:metabolism; D045744:Cell Line, Tumor; D015180:Electrophoresis, Gel, Two-Dimensional; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D008545:Melanoma / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000737:chemistry*; D010710:Phosphates / Q000737:chemistry*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000378:metabolism; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000737:chemistry / Q000378:metabolism; D013873:Thionucleotides / Q000737:chemistry*
chemical_list: D014408:Biomarkers, Tumor; D007773:Lactates; D016376:Oligonucleotides, Antisense; D010710:Phosphates; D019253:Proto-Oncogene Proteins c-bcl-2; D034741:RNA, Small Interfering; D013873:Thionucleotides; D018799:Intercellular Adhesion Molecule-1; C083120:phosphorodithioic acid; C408162:oblimersen